Suppr超能文献

抗生素耐药性的时间箭头:外排泵诱导是分枝杆菌药物耐药性进化的普遍第一步。

The antibiotic resistance arrow of time: efflux pump induction is a general first step in the evolution of mycobacterial drug resistance.

机构信息

Department of Medicine, University of Texas Southwestern Medical Center, School of Pharmacy, Dallas, Texas, USA.

出版信息

Antimicrob Agents Chemother. 2012 Sep;56(9):4806-15. doi: 10.1128/AAC.05546-11. Epub 2012 Jul 2.

Abstract

We hypothesize that low-level efflux pump expression is the first step in the development of high-level drug resistance in mycobacteria. We performed 28-day azithromycin dose-effect and dose-scheduling studies in our hollow-fiber model of disseminated Mycobacterium avium-M. intracellulare complex. Both microbial kill and resistance emergence were most closely linked to the within-macrophage area under the concentration-time curve (AUC)/MIC ratio. Quantitative PCR revealed that subtherapeutic azithromycin exposures over 3 days led to a 56-fold increase in expression of MAV_3306, which encodes a putative ABC transporter, and MAV_1406, which encodes a putative major facilitator superfamily pump, in M. avium. By day 7, a subpopulation of M. avium with low-level resistance was encountered and exhibited the classic inverted U curve versus AUC/MIC ratios. The resistance was abolished by an efflux pump inhibitor. While the maximal microbial kill started to decrease after day 7, a population with high-level azithromycin resistance appeared at day 28. This resistance could not be reversed by efflux pump inhibitors. Orthologs of pumps encoded by MAV_3306 and MAV_1406 were identified in Mycobacterium tuberculosis, Mycobacterium leprae, Mycobacterium marinum, Mycobacterium abscessus, and Mycobacterium ulcerans. All had highly conserved protein secondary structures. We propose that induction of several efflux pumps is the first step in a general pathway to drug resistance that eventually leads to high-level chromosomal-mutation-related resistance in mycobacteria as ordered events in an "antibiotic resistance arrow of time."

摘要

我们假设低水平外排泵的表达是分枝杆菌高水平耐药发展的第一步。我们在分枝杆菌属分枝杆菌-细胞内复合感染的中空纤维模型中进行了为期 28 天的阿奇霉素剂量效应和剂量方案研究。微生物杀灭和耐药出现与巨噬细胞内浓度-时间曲线下面积(AUC)/MIC 比值密切相关。定量 PCR 显示,3 天内低于治疗剂量的阿奇霉素暴露导致 MAV_3306(编码假定 ABC 转运蛋白)和 MAV_1406(编码假定主要易化因子超家族泵)的表达增加了 56 倍,在鸟分枝杆菌中。到第 7 天,遇到了具有低水平耐药的鸟分枝杆菌亚群,并表现出与 AUC/MIC 比值的典型倒 U 曲线。耐药性被外排泵抑制剂所消除。虽然最大的微生物杀灭作用在第 7 天后开始下降,但在第 28 天出现了高水平阿奇霉素耐药的种群。外排泵抑制剂无法逆转这种耐药性。在结核分枝杆菌、麻风分枝杆菌、海分枝杆菌、脓肿分枝杆菌和溃疡分枝杆菌中,均发现了由 MAV_3306 和 MAV_1406 编码的泵的同源物。所有这些同源物都具有高度保守的蛋白质二级结构。我们提出,几种外排泵的诱导是耐药发展的一般途径的第一步,最终导致分枝杆菌高水平染色体突变相关耐药性,作为“抗生素耐药时间箭头”中的有序事件。

相似文献

1
The antibiotic resistance arrow of time: efflux pump induction is a general first step in the evolution of mycobacterial drug resistance.
Antimicrob Agents Chemother. 2012 Sep;56(9):4806-15. doi: 10.1128/AAC.05546-11. Epub 2012 Jul 2.
2
Efflux pumps of Mycobacterium tuberculosis play a significant role in antituberculosis activity of potential drug candidates.
Antimicrob Agents Chemother. 2012 May;56(5):2643-51. doi: 10.1128/AAC.06003-11. Epub 2012 Feb 6.
4
Antimicrobial efflux pumps and Mycobacterium tuberculosis drug tolerance: evolutionary considerations.
Curr Top Microbiol Immunol. 2013;374:81-108. doi: 10.1007/82_2012_300.
5
Molecular modelling and simulation studies of the Mycobacterium tuberculosis multidrug efflux pump protein Rv1258c.
PLoS One. 2018 Nov 26;13(11):e0207605. doi: 10.1371/journal.pone.0207605. eCollection 2018.
7
The Mycobacterial Efflux Pump EfpA Can Induce High Drug Tolerance to Many Antituberculosis Drugs, Including Moxifloxacin, in Mycobacterium smegmatis.
Antimicrob Agents Chemother. 2021 Oct 18;65(11):e0026221. doi: 10.1128/AAC.00262-21. Epub 2021 Aug 23.

引用本文的文献

1
Sulbactam-Durlobactam Plus Ceftriaxone Dosing and Novel Treatment Regimens for Lung Disease.
bioRxiv. 2025 Aug 7:2025.08.05.668504. doi: 10.1101/2025.08.05.668504.
3
Antimicrobial resistance mechanisms in non-tuberculous mycobacteria.
Folia Microbiol (Praha). 2025 Jun 28. doi: 10.1007/s12223-025-01287-z.
5
Rhodamine6G and Hœchst33342 narrow BmrA conformational spectrum for a more efficient use of ATP.
Nat Commun. 2025 Feb 18;16(1):1745. doi: 10.1038/s41467-025-56849-z.
6
Fluoroquinolones and rifampin combination in the backdrop of heteroresistant tuberculosis.
Antimicrob Agents Chemother. 2025 Feb 13;69(2):e0108424. doi: 10.1128/aac.01084-24. Epub 2025 Jan 16.
7
Association Between Diabetes Mellitus-Tuberculosis and the Generation of Drug Resistance.
Microorganisms. 2024 Dec 20;12(12):2649. doi: 10.3390/microorganisms12122649.
8
Antibacterial action of penicillin against .
IJTLD Open. 2024 Aug 1;1(8):362-368. doi: 10.5588/ijtldopen.24.0238. eCollection 2024 Aug.
9
EfpA is required for regrowth of following isoniazid exposure.
Antimicrob Agents Chemother. 2024 Aug 7;68(8):e0026124. doi: 10.1128/aac.00261-24. Epub 2024 Jul 22.
10
Ertapenem's therapeutic potential for Mycobacterium avium lung disease in the hollow fibre model.
Int J Antimicrob Agents. 2024 Sep;64(3):107204. doi: 10.1016/j.ijantimicag.2024.107204. Epub 2024 May 15.

本文引用的文献

2
Multidrug-resistant tuberculosis not due to noncompliance but to between-patient pharmacokinetic variability.
J Infect Dis. 2011 Dec 15;204(12):1951-9. doi: 10.1093/infdis/jir658. Epub 2011 Oct 21.
4
Pharmacokinetic/pharmacodynamic-based treatment of disseminated Mycobacterium avium.
Future Microbiol. 2011 Apr;6(4):433-9. doi: 10.2217/fmb.11.25.
5
Rifampicin reduces susceptibility to ofloxacin in rifampicin-resistant Mycobacterium tuberculosis through efflux.
Am J Respir Crit Care Med. 2011 Jul 15;184(2):269-76. doi: 10.1164/rccm.201011-1924OC. Epub 2011 Apr 21.
6
Rapid assessment of antibacterial activity against Mycobacterium ulcerans by using recombinant luminescent strains.
Antimicrob Agents Chemother. 2010 Jul;54(7):2806-13. doi: 10.1128/AAC.00400-10. Epub 2010 Apr 26.
10
Neutrophils are the predominant infected phagocytic cells in the airways of patients with active pulmonary TB.
Chest. 2010 Jan;137(1):122-8. doi: 10.1378/chest.09-0903. Epub 2009 Sep 11.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验